text:
Kingsmen make believers of Wilsonville
Putnam makes school history with a double overtime victory
The unheralded Rex Putnam Kingsmen pulled off the biggest upset in Class 5A football last Friday, knocking off fourth-ranked Wilsonville 28-26 in double overtime, to the delight of Putnam players, coaches and home fans.
It was the first time in Putnam school history that the Kingsmen had ever beaten Wilsonville in varsity football.
The teams had never played one another before 2010. Wilsonville won 35-13 in 2010, 45-21 in 2011 and 51-14 last fall.
Wilsonville went 6-1 in the NWOC and finished second in the conference to Class 5A state champion Sherwood (13-0, 7-0) in 2012.
Fridays Kingsmen victory was the first loss of the 2013 season for the Wildcats, who had outscored three earlier opponents this season by an average score of 29-8 defeating Parkrose (42-6), St. Helens (21-12) and 6A Sprague (23-7) in earlier games.
Parkrose entered play this week ranked No. 1 in the OSAA Class 5A power rankings; Putnam, with losses in its first three games, was ranked 19th; Sprague was ranked No. 1 in 6A.
Entering last Fridays home game, the Kingsmen (1-3, 1-1) had lost their three previous games by an average score of 48-19 with losses to fifth-ranked Hermiston (48-7), 12th-ranked Sandy (33-14) and Crescent Valley (63-35).
Last Fridays game at Putnam ended in a 13-13 tie in regulation, but the Kingsmen wouldnt even have had a chance to tie without the heroics of Putnam senior kicker Bella Geist.
Trailing 13-10 with two minutes remaining in regulation, the Kingsmen received a punt and went on the march. But it appeared like they would come up short of the end zone before the game clock ran out.
Enter Geist, who sent a 36-yard field goal over the bar as time expired in regulation.
I didnt actually see it go over, but I was told it went right down the middle, but was close in terms of distance, said Geist. As soon as I kicked it, someone dove at my feet and I fell backwards.
Both teams scored touchdowns and made their PAT kicks in the first overtime. After Wilsonville scored, Putnam quarterback Josey Swain connected with John Bradley for a 25-yard touchdown on a swing pass; Geist split the uprights on the PAT to make it 20-20, and the second overtime followed.
Swain hooked up with Bradley for a 20-yard touchdown pass play in the second overtime, putting the Kingsmen up 26-20. That play was also a swing pass.
The Kingsmen then put what would prove the winning points on the scoreboard with an unplanned two-point conversion on the PAT. They lined up for a kick, but instead Swain found wide receiver Brandon Culp wide open in the end zone for the two-point conversion, making it 28-20 Putnam.
The Cats answered with a touchdown on their possession of the second overtime. But their attempt to pass for the two-point conversion was deflected away from the receiver by Culp.
It was supposed to be a kick, but the snap was low, Geist said of Putnams successful two-point PAT conversion. Josey is my holder, and with the low snap, he didnt think we would be able to get the kick off. So he shouted Fire, which means were not going to get the kick off.... Brandon shot off the line. There was no one around him, and he caught the ball.
Geist earlier in the game had split the uprights on a 34-yard field goal that put the Kingsmen ahead 10-6.
Putnam scored its only touchdown of regulation on a 13-yard run by Richie Mock-Seratt in the first quarter.
Geist, who has been Putnams PAT kicker since her sophomore year, says that before last Fridays game shed only been asked to kick a field goal once in a game. It was a 30-yarder; it was long enough, but it went wide, she says.
Ive made one from 40 yards in practice, said Geist, who is the goalie for Putnams girls soccer team.
Putnam sophomore safety Jesse Countryman came up with a key defensive play late in the third quarter to keep the Kingsmen in the game, intercepting a pass by Wilsonville quarterback Chase Eisenbrandt in the red zone.
Asked if his players may have underestimated the Kingsmen, Wilsonville coach Adam Guenther said: Absolutely despite many warnings.... [Putnam is] better than their record. They played a heck of a game and deserved to win.
Guenther added: Holy cow. If you paid your five dollars tonight, you got your moneys worth.
The team this year is really young, but they have a lot of fight, said Geist. We went into the game with a winning attitude, but no one would be believe in us but us. The fans even stayed away from the [Wilsonville] game because Wilsonville was supposed to be really good, and the fans thought theyd slaughter us.
We know what we can do now and theres no reason we cant be top 10 in the state.
The Kingsmen will get a chance to prove that last Fridays win was no fluke this Friday, when they entertain Parkrose (3-1, 1-1). The Broncs have wins this season over Franklin (54-6), Jefferson (25-6) and Sandy (43-24).
Wilsonville (3-1, 2-1) on Friday has a nonleague game at Mt. View.
Big plays
sink Milwaukie
Victory continued to elude Milwaukies football team Friday night at Liberty, as the Mustangs slipped to 0-4 on the season and 0-2 in the Northwest Oregon Conference with a 29-12 loss to the Falcons.
The Mustangs kept the game close until the third period, when Falcon 5-7, 160-pound sophomore running back Devin Kaneshiro returned the second-half kickoff 76 yards for a touchdown.
A short time later, Liberty 6-4, 160-pound sophomore quarterback Blake Walker hooked up with 6-3, 205-pound wide receiver Byron Greenlee for a 40-yard touchdown pass play, and the Falcons were in charge, leading 29-6.
The Falcons hurt the Mustangs with the big play all night, scoring the games first touchdown when 160-pound junior Nick Bonat busted a 54-yard run to the end zone.
Leading 7-6, the Falcons scored on a 73-yard screen pass from Walker to 175-pound senior Matt Langbehn near the midpoint of the second period, giving them a 15-6 lead at the intermission.
Milwaukie scored in the first period on a 7-yard pass from 6-4 senior Tyler Spencer to junior Garrett Zundel; and in the fourth quarter, on a 19-yard pass from freshman Jonathon Snyder to Spencer.
Spencer had a pretty good night passing, completing 9-of-17 aerials for 120 yards; Snyder connected on 7-of-14 passes for 65 yards.
But the Mustangs continued to struggle to get their running game going. Dre Edwards rushed six times for 26 yards to head up a Milwaukie ground attack that netted just 65 yards.
Walker had a great night for the Falcons, completing 14-of-18 passes for 261 yards. Langbehn made four catches for 91 yards.
Bonat rushed four times for 67 yards to lead the Falcon ground game.
With the win, Liberty improved to 3-1 on the season and 2-0 in the NWOC. The Falcons also have wins over St. Helens (34-33) and over Churchill (38-21). Their loss came in their season opener with Hillsboro (24-12).
Milwaukie returns home Friday, hosting Sandy (3-1, 1-1). After opening the season with wins over Hood River (47-21), Wilson (14-6) and Putnam (33-12), the Sandy Pioneers tasted their first defeat last Friday, losing 43-34 at Parkrose.
Milwaukie won 42-23 in last years NWOC game at Sandy.


text:
The 2013 tour will start in Boulder on Monday, April 1 and will conclude in Glenwood Springs on Saturday, April 6. The tour in total will visit 20 cities in six days.
The tour will visit three-to-four cities per day throughout the week and will include autographs and photos with Broncos players, cheerleaders and Miles the Mascot. As a way to thank fans for their loyalty, passion and on-going support, each tour stop will be free and open to the public.
"We're very excited to bring this tour to each of the 20 cities next month," said Mac Freeman, Sr. Vice President of Business Development. "The Mile High Salute to Fans Tour will allow us to get out and thank fans throughout Broncos Country for their on-going support. Spending time in the communities that support us so passionately is extremely important to everyone in the Broncos organization."
The tour will visit the following cities from Monday, April 1 through Saturday, April 6.
April 1 - Boulder, Longmont, Loveland and Eaton
April 2 - Julesburg, Brush and Fort Morgan
April 3 - Limon, Flagler, Stratton and Burlington
April 4 - Lamar, Las Animas and Pueblo
April 5 - Gunnison, Montrose and Delta
April 6 - Grand Junction, Rifle and Glenwood Springs
Fans can visit DenverBroncos.
com/SaluteToFansTour for complete tour stop details.

subset: commoncrawl


text:
Judge greenlights extradition of 'Pentagon hacker'
Home Secretary to consider case
District Judge Evans has given the go ahead for the extradition of alleged Pentagon hacker Gary McKinnon to the United States.
The Judge said he was satisfied that the extradition would be compatible with McKinnon's convention rights. The case will now be considered by the Home Secretary.
The Judge said he was satisfied that on the reassurances given by the US attorney and government, McKinnon would not face charges that could see him end up in Guantanamo Bay.
McKinnon is accused of causing damage to US military and NASA computers during the course of a hacking spree he allegedly conducted in search of evidence that the government was in possession of alien technology salvaged from wrecked UFOs.
He feared that he would face tough US anti-terrorist charges if he were extradited. The US had provided written assurances that though he would be tried as someone who had tried to "endanger the public safety" by "causing harm to the US government", he would not be tried as a terrorist. He was never given the Presidential waiver that his defence team said would be the only sure way to avoid prosecution as a terrorist.
However, Judge Evans maintained that the US was unlikely to break written assurances given in honour of a 100 year old extradition agreement with Britain.
John Reid, the Home Secretary, will now decide whether to extradite McKinnon in consideration of the statement made by Judge Evans. McKinnon will argue that the US can't be trusted to handle his case fairly. If that fails he will take his case to the High Court.
In a statement given outside the court, McKinnon's team argued, "If extradited for offences which could readily be subjected to Military Order No. 1 and detained indefinitely without trial or effective remedy in the US and that his human rights would be substantially infringed, quite apart from his vulnerability, if tried in the US domestic courts, to a prison sentence wholly disproportionate to his crimes."
McKinnon has been processed under controversial extradition laws that give the United States the unreciprocated power to have people extradited without having to provide prima facie evidence.
He claimed to have not damaged information stored on the computers he broke into over an old fashioned 56K modem connection over 2001 and 2002.
He was in search of information that would prove a conspiracy put about by the The Disclosure Project, which claims to have witness testimonies from military and intelligence personnel that tell how anti-gravity and free energy devices have already been gleaned from crashed alien ships.
McKinnon has claimed he wanted to unearth the secrets for the benefit of mankind: "Old-age pensioners can't pay their fuel bills, countries are invaded to award oil contracts to the West, and meanwhile secretive parts of the secret government are sitting on suppressed technology for free energy," he said in an interview with the BBC last Friday.
He said he was caught while viewing on a NASA computer what he believed to be an image of a UFO that had been erased from a satellite image - something that is supposedly done routinely at building eight of NASA's Johnson Space Centre in Texas.®
Sponsored: Minds Mastering Machines - Call for papers now open


text:
|Episode Description
|Sunday, Jan 6, 2013 - 9:00 AM
"Keeping It Local"
In this episode, Allen discusses the importance of buying locally in your community or growing your own. He shares tips on planting gourds and when to harvest garlic. Plus, instead of using an artificial tree, we talk to an expert about buying from a local Christmas Tree Farm. D
|More on LEARN/CREATE (MT)
|No upcoming shows in database
|Previous on LEARN/CREATE (MT)
|No Past shows in database


text:
CHAPEL HILL – UNC Student Body President, Christy Lambden, says a task force set out to define the University's new sexual assault policy has decided the most efficient way to rewrite it is not line-by-line, but by looking at it with a broader lens.
"We've broken it down so that, in one half of the day, we discuss definitions, and in the second half, we discuss process and how the process at UNC and the ways that we can streamline the process and make it easier," Lambden says.
Lambden says the task force is making good progress.
After two full-day meetings, he says there is a lot of discussion between members of the task force and there is a wide variety of opinion.
When the group first met, some members were concerned that it would take some time for everyone to be comfortable talking in mixed company about the sensitive and often polarizing subject of sexual assault. However, Lambden says that members of the group have reached a point where they're comfortable expressing themselves.
"There's been a certain bonding among the task force and now everyone is completely confident and completely at ease with being able to voice their opinions on all matters related to the policy," Lambden says.
The task force has no set timeline but members say they plan to have the new policy written by the fall semester.


text:
SYS-CON.TV Webcasts
Did you read today's front page stories & breaking news?
Top Links You Must Click On
From the Wires
Kronos Reports Exceptional First-Quarter Results; Workforce Management Cloud Revenue Increases 106%
By: Business Wire
Feb. 5, 2013 10:00 AM
Kronos Incorporated today announced financial results, company advancements, and customer successes for the first quarter of Fiscal 2013. Kronos revenue for the quarter increased 13 percent to $224.2 million. Earnings before interest, tax, depreciation and amortization (EBITDA) increased 18 percent to $66.7 million.1
"We delivered outstanding growth in our first quarter – including a 106-percent increase in workforce management cloud revenue," said Aron Ain, Kronos chief executive officer. "Our award-winning products are ushering in a new era of innovation whereby organizations are empowered to manage in the moment. With our innovative product portfolio, fast-growing cloud business, deep vertical expertise, and unmatched global capabilities, Kronos is perfectly poised to continue to gain market share in 2013 and beyond."
First-Quarter News Facts
About Kronos Incorporated
Kronos is the global leader in delivering workforce management solutions in the cloud. Tens of thousands of organizations in more than 100 countries — including more than half of the Fortune 1000® — use Kronos to control labor costs, minimize compliance risk, and improve workforce productivity. Learn more about Kronos industry-specific time and attendance, scheduling, absence management, HR and payroll, hiring, and labor analytics applications at www.kronos.com. Kronos: Workforce Innovation That Works™.
© 2013 Kronos Incorporated. All rights reserved. Kronos and Workforce Central are registered trademarks and Workforce Ready, Workforce Tablet, Workforce Task Management, Workforce Analytics, TeleStaff, and InTouch are trademarks of Kronos Incorporated or a related company. All other trademarks are property of their respective owners.
Footnote 1: Revenue excludes purchase accounting adjustments related to the company going private in June 2007 and its acquisitions since June 2007 and includes timing adjustments related to international product deliveries which management includes when evaluating operating results. EBITDA excludes purchase accounting adjustments, FAS 123R charges, and non-recurring, unusual charges.
Enterprise Open Source Magazine Latest Stories . . .
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week


text:
Alexander Gilkes has partied with Jay Z in Paris and toured vineyards with the rapper, too.
They made the mistake—they partied—and now they have to deal with the repercussions.
I was leaving for California the next day, so Katie stayed and partied with me at a place in Cortland that serves kids drinks.
Mostly, they partied, which, for Kenney and his friends, meant doing cocaine.
He partied too much and had bad grades, but no more than most college kids.
He only says that he partied hard after getting the news and then lost in his next tournament.
Earlier this week, 24-year-old Princess Beatrice partied at Bodo's in a tight, leather miniskirt.
He said he never met Tsarnaev, but knew people who partied with him.
The longer they partied, the more un-celebrity-like they became.
While Britain partied, the rest of the world continued to fall apart.
"have a good time," 1922, from party (n.). Earlier as "to take the side of" (1630s). Related: Partied; partying.
late 13c., "part, portion, side," from Old French partie "side, part; portion, share; separation, division" (12c.), literally "that which is divided," noun use of fem. past participle of partir "to divide" (see part (v.)). Political sense of "side in a contest or dispute" evolved by 1300; meaning "a person" is from mid-15c. Sense of "gathering for social pleasure" is first found 1716, from general sense of persons gathered together (originally for some specific purpose, e.g. dinner party, hunting party). Phrase the party is over is from 1937; party line is first recorded 1834 in the sense of "policy adopted by a political party," 1893 in the sense of "telephone line shared by two or more subscribers." Party pooper is from 1951, American English.
(also partay)Togotoor give parties; be energetically social; live it up, make whoopee: You don't party with the right people, kiss your ass good-bye (1922+)
Related Terms
cold-meat party, gi party, have a party, hen party, kick party, necktie party, pop party, pot party, stag, tailgate party


text:
Welcome to Ultimate Subaru Message Board, my lurker friend!
|Welcome to Ultimate Subaru Message Board, an unparalleled Subaru community full of the greatest Subaru gurus and modders on the planet! We offer technical information and discussion about all things Subaru, the best and most popular all wheel drive vehicles ever created.
We offer all this information for free to everyone, even lurkers like you! All we ask in return is that you sign up and give back some of what you get out - without our awesome registered users none of this would be possible! Plus, you get way more great stuff as a member! Lurk to lose, participate to WIN*!
* The joy of participation and being generally awesome constitutes winning
** Not an actual guarantee, but seriously, you probably won't regret it!
Serving the Subaru Community since May 18th, 1998!
Fair Price for LSD Rear end + Rear Discs
Posted 12 October 2004 - 07:33 PM
I just found an 89 RX Turbo 3-dr hatch with 156K at the jy today. It's got an LSD rear diff and rear discs I wanna use for my 88 EA-81 4wd hatch (yes, I know I will have to convert to 3.9 ratio on the new LSD)
anyway, the price is $150 for the whole damn rear end, including axles and trailing arms (which I don't need but that's the deal)
Is $150 a fair price even at that mileage? this stuff is getting rare in the NE...
anyone know if I can reuse the axles?
any must have tools to pull the stuff?
Thanks in advance for any advice!
I'm new to the board, but I've had a lifted hatch since way back in the day (ok more like 1999 ), just now getting back into it!
Posted 12 October 2004 - 07:42 PM
to pull it out all you should need is your typical 10, 12, 14, 17, 19mm sockets and wrenches. You'll want to bring a breaker bar as well. And a hacksaw in case the exhaust is still there. Just unbolt the diff from the mustache bar, undo the subframe bolts near the front of the suspension, unbolt the driveshaft, coilovers, fuel pump brackets and cut or undo the brake lines. Then pull the whole setup out.
Posted 12 October 2004 - 07:45 PM
Offer him $120 and see where it goes from there.
Posted 12 October 2004 - 08:06 PM
Stinky, you put it into good perspective, I think I will get the rear end, but I actually already talked him down from $200! and I really don't think he knew or cared that it was LSD/Rear Discs! He was mostly concerned about the axles, which he said he could sell for $50 a piece.
I suppose $150 is a decent price if the parts are good (I do get a 15 day guarantee.)
I was just kinda hoping for a steal since chances are the thing would have been scrap by next week if I hadn't come along...
Posted 12 October 2004 - 10:02 PM
Posted 12 October 2004 - 11:46 PM
Posted 13 October 2004 - 12:26 AM
You make it sound like you have easy access to LSD... and I wanna get high (but don't have the traction).
I generally charge $125 for the LSD and $90 for the rear disks. They usually sell in a week or two. Off Board to others I hold out for more on the LSD but I never sold one off Board yet.
Edit: This was meant to be a serious question.
Posted 13 October 2004 - 01:45 AM
You make it sound like you have easy access to LSD... and I wanna get high (but don't have the traction).
Edit: This was meant to be a serious question.
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users


text:
*HTML is ON
*UBB Code is ON
Smilies Legend
Smilies Legend
If you have previously registered, but forgotten your password, click here.
T O P I C R E V I E WfredtravI bought several copies of Buzz Aldrin's signed new book. I bought them primarily for collectors overseas so they would have a chance to purchase one. I am selling them for my cost of $32 ($26 plus tax and shipping to me), plus actual shipping cost to wherever it goes. I have one copy left so if any one needs a copy let me know. Charlie16email sent.fredtravBook spoken for. If anyone else overseas wants me to try and find them one let me know. I am not making any money on this just trying to help fellow collectors overseas. lordolsenI am in for one! This would be great!fredtravAs I said the book that I had is spoken for. I have had several more requests, but I will be out of town until the 1st of June. When I get back I will try and find some more signed books to help out friends across the pond.Email me if you would like one and when I return I will let you know the status.
Email me if you would like one and when I return I will let you know the status.
Contact Us | The Source for Space History & Artifacts
Copyright 2018 collectSPACE.com All rights reserved.


text:
Recently departed Jazz Musician Gill Scott Heron's seminal piece was a song called "Winter in America". I think Gill Scott saw the destruction of the American Dream years before it reached the crisis point.
Something is really, really wrong here – and other than a few intrepid groups like "Take Back the Land" – there doesn't seem to be anyone in power doing a damn thing about it.
The right wing in this country is spending a lot of time defending the banks, the major corporations, and the rich by foisting one Trojan Horse issue after another upon the public airwaves.
A $15 a year tax break isn't going to save you from being foreclosed on your house.
Protesters 'Liberate' Foreclosed Homes
When Virginia Henry bought her boarded-up and abandoned Rochester, N.Y., home in December 2007, she saw potential where others were blind to it. The house, a short sale, became her home to live in and care for, she said. She plopped down her $20,000 and filed her paperwork for a loan program that would pay the balance — $43,000 — to rehabilitate the property.
But what followed was a series of unanswered calls and letters to Bank of America, Henry says, eventually culminating in her arrest Friday for a charge of trespassing on her own front lawn. The arrest, like much of this story, is the source of a dispute. Henry asserts police officers shoved her to the ground during the arrest, police claim she fainted from the intense heat. She has a court date for the trespassing charge July 28.
The facts of the short sale are also at issue. The bank has told Henry that the short sale never closed and that the house at 5 Appleton St. — with all her worldly possessions trapped inside — is no longer hers. A Bank of America spokeswoman, Jumana Bauwens, said she would investigate the claims.
"This is my home," Henry told AOL Real Estate in a phone interview after the arrest. "How can I be trespassing in my own home?"
Protesters Step In
Read the rest of this entry »


text:
1690 - Aaron MENDENHALL born. Aaron was the son of John MENDENHALL and Elizabeth MARIS.
1708 - William DIXON died in Christiana Hundred, New Castle County, Delaware. William was the son of Thomas DIXON and Rose ________.
1722 - Lydia BABCOCK married Roger ELDERTON in Westerly, Rhode Island. Lydia was the daughter of Robert BABCOCK and Lydia CRANDALL.
1742 - Joshua MAXSON married Anna SLACK in Washington County, Pennsylvania. Joshua was the son of John MAXSON and Hannah MAXSON.
1750 - Johann Friedrich KAHRE born in Kummerdinsen, Westphalia. Johann was the son of Johann Jurgen KAHRE and Catherine Margarethe KAMMEIER.
1756 - Lucretia DAVIS born. Lucretia was the daughter of Joseph DAVIS and Mary BABCOCK.
1772 - Coleby CHEW born in New London, Connecticut. Coleby was the son of Samuel CHEW and Lucy MILLER.
1779 - Mary NESBIT born in Virginia. Mary was the daughter of Samuel NESBIT and Mary BERRY.
1779 - Hannah THORNBURGH born. Hannah was the daughter of Thomas THORNBURGH and Abigail BROWN.
1786 - Jane GAMBLE born. Jane was the daughter of John GAMBLE and Rebecca McPHEETERS.
1789 - Elizabeth RAINS born. Elizabeth was the daughter of Anthony RAINS and Nancy GRAHAM. Elizabeth was my 5x-great grandmother.
1809 - Charity MENDENHALL died in Guilford County, North Carolina. Charity was the daughter of Richard BEESON and Charity GRUBB. Charity was my 7x-great grandmother.
1815 - John MAXON died in Fayette County, Pennsylvania. John was the son of Joel MAXON and Hannah FIELDS.
1817 - Anne WOOLSTON married Joshau WOOLSTON in Burlington County, New Jersey. Anne was the daughter of Samuel WOOLSTON and Hannah HAINES.
1826 - Ithamar Warner WILLIAMS born in Guilford County, North Carolina. Ithamar was the son of Richard WILLIAMS and Sarah RUSSELL.
1829 - William R. DAVIS born. William was the son of Nathan J. DAVIS and Keziah DAVIS.
1840 - William Wesley LeMASTERS born in Holmes County, Ohio. William was the son of John LEMASTERS and Mary H. BAKER.
1840 - Nancy Ann WRIGHT born in Brown County, Ohio. Nancy was the daughter of John WRIGHT and Anna WARDLOW.
1843 - Milton CARTER married Louisa Ann HODSON in Hendricks County, Indiana. Milton was the son of Jesse CARTER and Nancy KENDALL.
1855 - George McLANE born in Rimer, Putnam County, Ohio. George was the son of William Fleming McLANE and Elizabeth GUFFY.
1873 - Osa MENGLE born. Osa was the son of David L. MENGLE and Ellen W. LAMBERTSON.
1879 - John BYERS died in Burbank, Ohio. John was the son of Abraham BYERS and Mary STICKEL.
1888 - Ephraim JACOBS died in Adams County, Ohio. Ephraim was the son of William JACOBS and Sibel LITTELL.
1893 - Ruth Eleanor WEHRLY born. Ruth was the daughter of John William WEHRLY and Esther L. WHITE.
1898 - Jesse Ray SWAFFORD born in Ray County, Missouri. Jesse was the son of Allen Aaron SWAFFORD and Anna S. COVEY.
1908 - Nellie LEE married Olie THOMPSON. Nellie was the daughter of William Burrell LEE and Margaret Jane SWAFFORD.
1969 - Clinton S. SWAFFORD died in Richmond, Missouri. Clinton was the son of Clinton A. SWAFFORD and Lena LIERMAN.


text:
NEW YORK ( TheStreet) - Hewlett Packard ( HPQ) has made it official. Less than one week after leaking some information its Web site (and then quickly taking it down) , the tech giant has formally announced its first Chromebook - the Pavilion 14. Chromebooks are lightweight laptop/notebook computers runnin Google's ( GOOG) Chrome OS, which is simply a Chrome browser. For the most part, that's it. The underlying operating system is a form of Linux. But, for the end user, all you need to know is that everything you can do on a Chromebook is done via the Chrome browser. Everything. Need to write an "Office" document? You do so using Google's online office suite. Need to store or share those documents? You do that in Google's Cloud. You can access that cloud from any computer with a Web browser then print it anywhere you need. There are also thousands of Chrome-based apps for nearly everything else. Everything from games, news and business sites, to photos, music and video. Just like a real computer. HP's new device has a full-size 14-inch screen (1,366 by 768 pixels), a 1.1 GHZ Intel ( INTC) Celeron processor, 2 GB of RAM and 16 GB of flash internal storage, a SD card slot and HDMI port. The device will retail for $329.99 when it goes on sale on Feb. 17. HP joins the ranks of Samsung and Acer, who've been making Chromebooks for years, as well as Lenovo. Last week Lenovo announced a Chromebook that it will sell to school systems nationwide. The new HP has similar specs to the $199 Acer C7, except for the larger display and battery. At the moment, Chromebooks are hot - the netbooks of today. Look at the latest ranking from Amazon.com ( AMZN) and you'll see the most popular laptop sold on the site is the Samsung Chromebook. It's currently listed as going for more than its $250 suggested retail price. In questionable economic times, buyers (especially bulk-purchasers such as school systems) look for the best deals. In our tests, we've found that Chromebooks are very capable and very affordable devices for many computer tasks. They're especially affordable when you consider that many popular tablets are selling for $500 to $600, Microsoft's ( MSFT) new Windows 8 Surface computers start in that same region (which is why initial sales are slow) and Apple's ( AAPL) MacBook Air begins at $1,000. I'm guessing we'll see more manufacturers - possibly Asus, Dell ( DELL), and others - as well as buyers - joining the Chromebook ranks as time goes on --Written by Gary Krakow in New York. >To submit a news tip, send an email to: email@example.com.
- Log In
- Newsletters
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
- Action Alerts PLUS
- Income Seeker
- Quant Ratings
- Real Money
- Real Money Pro
- Retirement Daily
- Stocks Under $10
- Top Stocks
- Trifecta Stocks
- Real Money Pro Portfolio
- Chairman's Club
- Compare All


text:
Want to remind yourself or a friend about this program? Fill out this simple form and klru will email you a reminder on the day that it will air.
Episode Details
series: Great American Seafood Cook-off
air date: 10/06/13 7:00 AM
Fires blazed and seafood sizzled as New Orleans hosted the fifth annual Great American Seafood Cook-Off in August 2008. During the two-day competition, 15 chefs from 14 different states prepared their best dishes using the seafood indigenous to their state. Famed New Orleans chef John Besh, the winner of the 2004 competition and the 2006 James Beard Foundation's Best Chef of the Southeast, hosted the event. GREAT AMERICAN SEAFOOD COOK-OFF contains the most dramatic highlights from the event. Overcooked fish and other culinary calamities cause major stress for the contestants as they attempt to create a masterpiece in three hours. Chef John Currence, a Louisiana native, ultimately prevailed, taking home the top prize for his combination of Mississippi redfish courtboullion and seafood dirty rice. Other entries included Colorado striped bass panzanella by chef Paul Anders (Colorado), pan-roasted glazed rockfish with peas and carrots by chef Tafari Campbell (Maryland) and Texas gulf shrimp by chef Mark Holley (Texas).
WARNING: Email reminders for this program have already been sent out. Your reminder may not reach the intended address in time for this program's airing.
Back to TV Schedule


text:
A sea-salt bath therapy for a remineralizing soak or all-over skin polishing. When used as a scrub, Sea Salts and Kelp help smooth and polish skin. As a soak, these ingredients combine with stress-reducing essential oils of Sandalwood, Lavender, Orange and Clary Sage to render skin silky-smooth.Learn More
A sea-salt bath therapy for a remineralizing soak or all-over skin polishing.Learn More
For a mineral soak: Pour a small amount into a warm bath. For a spa style exfoliation: Shake a small amount onto wet hands or mix into a paste with 2 pumps of Stress Relief Treatment Oil and gently massage over the entire body, concentrating on elbows, knees and heels.
Pour into your pedicure bath for an aromatherapeutic soak.
Sodium Chloride, Macrocystis Pyrifera (Kelp), Essential Oils of: Santalum Album (Sandalwood), Citrus Aurantium Dulcis (Orange), Lavandula Angustifolia (Lavender), Cedrus Atlantica (Cedarwood) Bark, Amyris Balsamifera Bark, Salvia Sclarea (Clary), Pogostemon Cablin, Cananga Odorata Flower, Lavandula Hybrida, Eucalyptus Globulus Leaf, Citrus Medica Limonum (Lemon) Peel, Rosmarinus Officinalis (Rosemary) Leaf, Melaleuca Alternifolia (Tea Tree) Leaf; Silybum Marianum Powder, Coriandrum Sativum (Coriander) Powder, Eugenia Caryophyllus Powder, Glycyrrhiza Glabra (Licorice) Powder, Ilex Paraguariensis Powder, Citrus Medica Limonum (Lemon Bioflavonoids) Peel Powder, Cymbopogon Schoenanthus Powder, Salvia Officinalis Leaf Powder, Chamomilla Recutita (Matricaria) Powder, Zingiber Officinale (Ginger) Root Powder, Berberis Vulgaris Powder, Cinnamomum Zeylanicum Bark Powder, Zea Mays (Corn) Starch, Oryza Sativa (Rice) Starch, Tapioca Starch, Avena Sativa (Oat) Kernel Flour, Papain, PPG-5-Ceteth-20, Limonene, Linalool., Benzophenone-4, Methylparaben, Ethylparaben.
Dermalogica is dedicated to maintaining the accuracy of the ingredient lists on this website. However, because ingredients are subject to change, we cannot guarantee that these lists are complete, up-to-date and/or error-free. For an accurate listing of ingredients in each product, please refer to your product packaging.
REVIEW SNAPSHOT®by PowerReviews
Reviewed by 8 customers
Comments about hydro-active mineral salts:
The smell is amazing. So clean. It scrubs you and leaves your skin moisturized. Good for women or men.
Comments about hydro-active mineral salts:
I used in my knees and elbow and leave my skin really smooth, the smell is so good
Comments about hydro-active mineral salts:
I used to love Dermalogica's body care. It's so hard to find fragrance free body products . But of course they discontinued many products. The oil mentioned above included. It's very hard to make this into a scrub without an oil to mix it with. What a shame. In stead of catering to customers it's become about the bottom line just like all the other companies.
Comments about hydro-active mineral salts:
Love the way this makes your skin feel soft. You just want to take in the soothing aroma. Would highly recommend this.
Comments about hydro-active mineral salts:
Smells so good and polishes my skin really well! Great for a relaxing soak in the tub.
Comments about hydro-active mineral salts:
I LOVE THIS PRODUCT SO MUCH!! The smell is amazing and so relaxing in a bath and my skin feels wonderful afterwards. If I'm in more of a hurry I mix this up like the instructions say with some oil and give myself a quick scrub. Even then the scent is so relaxing.
Comments about hydro-active mineral salts:
The smell s AMAZING!! I have used this in my bath water along with the Stress Relief Oil & also in pedicure bath for my clients to soak before pedicure.
Comments about hydro-active mineral salts:
Very soothing and relaxing bath. Eases tension for me.
Do you have questions about this product?
Get answers from Dermalogica Skin Therapists and our community.
Q:Is this considered an exfoliator? I am looking for an exfoliator for my body.
1 answer
A:Hello Kaelyn,
Q:Please quantify "small amount" for bath soak. I have been using a half of a tablespoon to a full tablespoon.
1 answer


text:
LAMGeneric Name: Levomethadyl
Levomethadyl acetate—Levacetylmethadol {02} .
Primary: CN101
Note: Controlled substance classification—
Commonly used brand name(s): Orlaam.
Other commonly used names are
LAAM, LAM, levacetylmethadol, levo-alpha-acetylmethadol, levomethadyl acetate, and MK790 {02} {03} {04} {05}.
Note: For a listing of dosage forms and brand names by country availability, see Dosage Forms section(s).
†Not commercially available in Canada.
Opioid (narcotic) abuse therapy adjunct—
Note: Levomethadyl is an opioid (narcotic) analgesic, but is not used for relief of pain.
General considerations
In the U.S., levomethadyl is permitted to be dispensed only through opioid addiction treatment programs approved by the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), and designated state authorities. Use of levomethadyl in such programs is subject to treatment requirements stipulated in Federal regulations. {01} {05}
Opioid (narcotic) drug use, illicit (treatment adjunct)—Levomethadyl is indicated as an adjunct to other measures, which may include psychological and social counseling and medical and rehabilitative services, in the treatment of opioid dependence {01} {05}. It may be used in detoxification programs (to assist withdrawal from illicit opioids) and in maintenance programs (to discourage illicit use of other opioids) {01} {05} {07}. Appropriate evaluation, planning, counseling, and follow-up are essential components of successful treatment {01}. There is no evidence that administration of an opioid alone is effective treatment for opioid addiction {01}.
Note: In the U.S., Federal regulations permit specific opioids (levomethadyl and methadone) to be used in approved detoxification and interim or comprehensive maintenance treatment programs {05}. Levomethadyl is administered only 3 times a week and may be particularly useful for patients who do not require daily visits to the clinic, whereas methadone must be administered every day and may be more useful for patients who benefit from the support of daily clinic visits {01}. Also, because some patients experience effects perceived as aversive during treatment with one opioid or the other, the selection of a particular opioid may depend on patient acceptance {07} {15} {16}.
Short-term (up to 30 days) or long-term (up to 180 days) detoxification programs use an opioid to alleviate adverse physiological or psychological consequences of withdrawal from illicit opioids, with dosage gradually being decreased until a drug-free state is achieved. After 180 days, patients who have not achieved a drug-free state are considered to be receiving maintenance treatment. Patients may also be enrolled directly into a maintenance program without first attempting detoxification. In maintenance treatment programs, relatively stable doses of opioid are given on a continuing basis as a substitute for illicit opioids. {05}
Detoxification and comprehensive maintenance programs must include a full range of medical and rehabilitative services in addition to opioid administration. However, patients who are awaiting admission to a comprehensive maintenance program may receive up to 120 days of interim maintenance treatment, which consists only of opioid administration and needed medical services. {05}
Physicochemical characteristics:
Chemical group—
Opioid analgesic; chemically related to both oxymorphone and naloxone {08}.
Molecular weight—
Levomethadyl acetate hydrochloride: 389.97 {02}
Octanol:water partition coefficient
405:1 {01}.
Mechanism of action/Effect:
Levomethadyl is a mu-receptor opioid agonist. It substitutes for opioids of the morphine type, thereby suppressing withdrawal symptoms in individuals who are addicted to such agents. With chronic use, levomethadyl produces cross-tolerance to the effects of other mu-receptor agonists, including the subjective ``high'' they produce, and decreases the addict's desire for such drugs. {01}
Other actions/effects:
Levomethadyl produces effects characteristic of mu-receptor opioid analgesics, including analgesia, respiratory depression, sedation, pupillary constriction, and physical dependence. {01}
Rapid {01}.
Extensive. The volume of distribution is about 20 L per kg of body weight (L/kg) {01}.
Protein binding:
High (approximately 80%); primarily to an alpha globulin {09}. Studies in heroin addicts {10} have demonstrated that levomethadyl, levomethadyl's active metabolites, and methadone bind to, compete for, and displace each other from the same protein-binding sites {09} {10}.
Levomethadyl undergoes extensive {11}first-pass metabolism {01} {11}to the active demethylated metabolite nor-levomethadyl (nor-LAAM), which is further demethylated to a second active metabolite, dinor-levomethadyl (dinor-LAAM). Smaller quantities of levomethadyl are also deacetylated to methadol, nor-methadol, and dinor-methadol. The rate of biotransformation is subject to interindividual variability. Although biotransformation to nor-LAAM generally occurs more slowly in males than in females, the differences are not as great as the interindividual differences. {01}
Levomethadyl: Approximately 6 hours {10}.
Levomethadyl: Approximately 2.6 days {01} {10}.
nor-LAAM: Approximately 2 days {01}.
dinor-LAAM: Approximately 4 days {01}.
Onset of action:
Although some opioid analgesic effects are apparent 2 to 4 hours after an oral dose, suppression of opioid withdrawal symptoms occurs after a delay of at least several days {01}, during which levomethadyl's active metabolites are forming and accumulating {01} {07}.
Time to peak concentration:
Levomethadyl—Usually 1.5 to 2 hours, {01} but up to 4 hours in some studies {10} {12}.
nor-LAAM—Usually 4 to 7 hours, but up to 10 hours in some individuals {11}.
dinor-LAAM—Usually 5 to 7 hours, but 24 to 48 hours in some individuals {11}.
Peak serum concentration
One study in 12 patients reported substantial interindividual variability in the peak concentrations of levomethadyl and its active metabolites after single and multiple doses. Plasma concentrations of levomethadyl, nor-LAAM, and dinor-LAAM were higher after multiple doses than after single doses, but the concentrations of the metabolites, especially dinor-LAAM, were increased to a greater extent than those of levomethadyl {11}.
Studies of peak and trough steady-state concentrations showed that there is great interindividual variability in levomethadyl concentrations over a 72-hour dosing interval. Also, although the concentration of levomethadyl itself decreased considerably during the 72-hour interval, the concentrations of the active metabolites, especially dinor-LAAM, decreased to a much lesser extent. {01}
Time to steady state
Three-times-per-week dosing schedule—1 to 2 weeks {01} (approximately 9, 8, and 12.5 days for levomethadyl, nor-LAAM, and dinor-LAAM, respectively). {11}
Time to peak effect
Suppression of opioid withdrawal symptoms—Approximately 7 to 10 days after initiation of treatment {01}.
Duration of action:
Suppression of opioid withdrawal symptoms:
Single 30- to 60-mg dose: 24 to 48 hours {01}.
Single 80-mg or higher dose: 48 to 72 hours {01}.
Approximately 27% of a dose is eliminated in the urine as levomethadyl and various metabolites (nor-LAAM, dinor-LAAM, methadol, nor-methadol, and dinor-methadol) {11}. The disposition of the remainder of the dose has not been determined in humans, but extensive biliary elimination has been demonstrated in animal studies {10}.
Precautions to Consider
Levomethadyl was not carcinogenic in 2-year studies in rats given 13 mg per kg of body weight (mg/kg) (77 mg per square meter of body surface area [mg/m 2]) or in mice given 30 mg/kg (90 mg/m 2) {01}.
Levomethadyl was not mutagenic in the Ames test, the unscheduled DNA synthesis and repair test, in vitro mouse lymphoma cell studies, or in vivo rat chromosomal aberration tests {01}. However, levomethadyl exhibited mutagenic activity in the ad-3 forward mutation assay in N. crassa in concentrations of 150 mcg per mL (mcg/mL) in vitro and in the heritable translocation assay in mice receiving 21 mg/kg (63 mg/m 2) {01} {08}. The significance of these findings to clinical use in humans is not known {01}.
Methadone is the agent of choice for pregnant women in comprehensive maintenance treatment programs {05}. There are no clinical data on the safety of levomethadyl during pregnancy {01}. Levomethadyl administration should not be started or continued during pregnancy {01} {05} except by the written order of a physician who determines levomethadyl to be the best choice of therapy for an individual patient {05}. In the U.S., Federal regulations require that women of childbearing potential receive a pregnancy test prior to initiation of, and monthly during, levomethadyl maintenance treatment {01} {05}.
Animal reproduction studies have not been completed {01}. However, in one study administration of 0.2 or 2 mg/kg per day to rats prior to and throughout gestation caused opioid dependence in both the dams and pups. The larger dose also produced high incidences of premature delivery, stillbirths, and decreased pup weights. However, there were no differences in the rates of implantation, resorption, or morphological abnormalities between treated and control groups. {13}
FDA Pregnancy Category C {01}.
Labor and delivery—
The effects of levomethadyl on labor and delivery are not known {01}.
Postpartum —
Use of levomethadyl during pregnancy may result in respiratory depression and/or physical dependence with delayed emergence of withdrawal symptoms in the neonate {01}.
It is not known whether levomethadyl is distributed into breast milk in quantities sufficient to affect the nursing infant {01}.
In the U.S., Federal regulations prohibit use of levomethadyl in addicts younger than 18 years of age {01} {05}.
No information is available on the relationship of age to the effects of levomethadyl in geriatric patients.
Opioid analgesics may decrease or inhibit salivary flow, thus contributing to the development of caries, periodontal disease, oral candidiasis, and discomfort.
Drug interactions and/or related problems
The following drug interactions and/or related problems have been selected on the basis of their potential clinical significance (possible mechanism in parentheses where appropriate)—not necessarily inclusive (» = major clinical significance):
Note: Combinations containing any of the following medications, depending on the amount present, may also interact with this medication.
» Alcohol or
» CNS depression–producing medications, other (See Appendix II ) (concurrent use may increase the CNS depressant, respiratory depressant, and hypotensive effects of these medications and/or levomethadyl; a reduction in dosage of levomethadyl and/or other prescribed CNS depressants may be required if concurrent use is necessary; also, opioid addicts should be warned of the risk of additive effects and potential for serious toxicity if they abuse alcohol or other CNS depressants while receiving levomethadyl {01})
» Enzyme inducers, hepatic, cytochrome P450 (see Appendix II ) (induction of the hepatic cytochrome P450 enzyme system may increase the rate of levomethadyl metabolism to its active metabolites and enhance its peak effectiveness, but may also shorten its duration of action {01})
» Enzyme inhibitors, hepatic (see Appendix II ) (inhibition of hepatic enzymes may slow the onset, lower the peak activity, and/or increase the duration of action of levomethadyl; adjustment of levomethadyl dosage and/or the interval between doses may be required {01})
» Opioid analgesics, mixed agonist/antagonist, such as:
» Opioid analgesics, partial mu-receptor agonist, such as:
Dezocine or
» Opioid antagonists, such as:
Naltrexone (these medications may precipitate withdrawal symptoms if administered to a patient receiving levomethadyl therapy; the severity of withdrawal symptoms will depend on the potency and dose of the antagonist or partial agonist and on the degree to which physical dependence is present {01})
(opioid analgesics such as levomethadyl will be ineffective if treatment is initiated in a patient receiving naltrexone, which blocks the therapeutic effects of opioids {21})
» Opioid analgesics, mu-receptor agonist, other, such as:
Sufentanil (chronic use of levomethadyl produces cross-tolerance to the therapeutic effects, but not necessarily to the toxic effects, of other mu-receptor opioid agonists, leading to a considerably higher-than-normal dosage requirement for other mu-receptor agonists and a substantial risk of additive toxicity; deaths have occurred early in levomethadyl treatment in opioid addicts who continued to use illicit opioids during the 1- to 2-week delay in levomethadyl's onset of action. Administration of a mu-receptor opioid analgesic to levomethadyl-treated patients, if necessary for therapeutic purposes, requires extreme caution and careful monitoring. Opioid agonists that are N-demethylated to long-acting, excitatory metabolites [e.g., meperidine, propoxyphene] should not be used because the high dosage requirement also leads to an unacceptably high risk of metabolite-induced toxicity {01})
Laboratory value alterations
The following have been selected on the basis of their potential clinical significance (possible effect in parentheses where appropriate)—not necessarily inclusive (» = major clinical significance):
Note: The following laboratory value alterations have not been documented with levomethadyl. However, they are commonly produced by other mu-receptor opioid agonists and should be considered potential effects of levomethadyl also.
Because of the long half-life of levomethadyl and its active metabolites, effects on laboratory values may persist for several days after treatment has been discontinued.
With diagnostic test results
Gastric emptying studies (opioid analgesics may delay gastric emptying, thereby invalidating test results {14})
Hepatobiliary imaging using technetium Tc 99m disofenin (delivery of technetium Tc 99m disofenin to the small bowel may be prevented because of opioid analgesic–induced constriction of the sphincter of Oddi and increased biliary tract pressure; these actions result in delayed visualization and thus resemble obstruction of the common bile duct {14})
With physiology/laboratory test values
Amylase, plasma and
Lipase, plasma (values may be increased because opioid analgesics can cause contractions of the sphincter of Oddi and increased biliary tract pressure {14})
Cerebrospinal fluid (CSF) pressure (may be increased; effect is secondary to respiratory depression–induced carbon dioxide retention {14})
Medical considerations/Contraindications
The medical considerations/contraindications included have been selected on the basis of their potential clinical significance (reasons given in parentheses where appropriate)— not necessarily inclusive (» = major clinical significance).
Risk-benefit should be considered when the following medical problems exist
Abdominal conditions, acute (diagnosis or clinical course may be obscured {01} )
» Asthma, acute attack or
» Respiratory depression, acute or
» Respiratory impairment or disease, chronic (risk of apnea because opioids decrease respiratory drive and increase airway resistance {01})
» Cardiac dysrhythmias (cases of QT interval prolongation and severe arrhythmias, including torsade de pointes, have been reported in patients using levomethadyl; levomethadyl may increase the risk of serious and possibly life threatening pro-arrhythmic effects, administer with extreme caution to patients who may be at risk for development of prolonged QT syndrome including congestive heart failure, bradycardia, use of a diuretic, cardiac hypertrophy, hypokalemia, or hypomagnesia; careful monitoring is recommended during therapy{24})
Dependence on or abuse of nonopioid medications, history of, including alcoholism or
Emotional instability or
Suicidal ideation or attempts (addicts often attempt suicide using combinations of opioids and other drugs of abuse. Patients who continue to use illicit opioids or other CNS-active medications despite adequate levomethadyl therapy require individualized evaluation and treatment planning; hospitalization may be necessary {01} )
Diagnostic, surgical, or other procedure requiring general anesthesia or sedation (levomethadyl-induced alterations in patient response to medications that may be used in conjunction with general anesthesia or sedation [e.g., tolerance to the therapeutic effects of mu-receptor opioid agonists; increased risk of severe CNS and/or respiratory depression with anesthetics, sedatives, and opioid analgesics] and the risk of precipitating withdrawal via use of opioid antagonists, mixed agonists/antagonists, or partial mu-receptor agonists must be taken into consideration when selecting medications and dosages to be administered {01} )
Diarrhea associated with pseudomembranous colitis caused by antibiotics or
Diarrhea caused by poisoning (opioids may slow the elimination of toxic material, and it is generally recommended that they not be administered until after toxins have been cleared from the gastrointestinal tract; {14} however, levomethadyl administration should not be interrupted if these conditions occur during treatment {22})
Gallbladder disease or gallstones (opioids may cause biliary colic {14})
Gastrointestinal tract surgery, recent (opioids may alter gastrointestinal motility {14} )
Head injury or
Increased intracranial pressure, pre-existing or
Intracranial lesions (increased risk of respiratory depression and further elevation of cerebrospinal fluid pressure; also, opioids may cause sedation and pupillary changes that may obscure the clinical course of head injury {01})
Hepatic function impairment or
Renal function impairment (although studies have not been done in patients with clinically significant hepatic or renal function impairment, the possibility must be considered that formation of levomethadyl's active metabolites and/or elimination of levomethadyl and its active metabolites may be substantially altered; because of its less complex metabolic profile, methadone may be preferable for such patients {01})
Hypothyroidism {01} (risk of respiratory depression and prolonged CNS depression is greatly increased)
» Inflammatory bowel disease, severe (risk of toxic megacolon may be increased {14})
Prostatic hypertrophy or obstruction or {01}
Urethral stricture or {01}
Urinary tract surgery, recent {14} (increased risk of urinary retention, which may be induced by these conditions as well as by opioids)
Sensitivity to levomethadyl, history of {01}
Patient monitoring
The following may be especially important in patient monitoring (other tests may be warranted in some patients, depending on condition; » = major clinical significance):
» Drug screen (in the U.S., Federal regulations mandate screening for drugs of abuse [amphetamines, barbiturates, cocaine, other opioids, and any other agents known to be abused in the program's locality] at the time a prospective patient first appears at the treatment center. Further testing is not required for patients undergoing detoxification from opioid drugs. Patients receiving interim maintenance treatment must be tested at least twice during a 120-day interim program, and patients receiving comprehensive maintenance treatment must be tested at least 8 times at random intervals during the first year of treatment and at least quarterly thereafter {05})
» Electrocardiogram (ECG) (all patients should undergo an initial ECG prior to administration of levomethadyl to determine if a prolonged QT interval is present (QT c greater than 430 [male] ms or 450 [female] ms). If there is a prolonged interval, levomethadyl should not be administered. For patients who would benefit from levomethadyl therapy, an ECG should be performed prior to treatment, 12 to 14 days after initiating treatment, and periodically thereafter.{24})
» Pregnancy test (in the U.S., Federal regulations require that women of childbearing potential receive a pregnancy test prior to initiation of, and monthly during, levomethadyl maintenance therapy {01} {05}because levomethadyl administration should not be started or continued during pregnancy {01} {05} except by the written order of a physician who determines levomethadyl to be the best choice of therapy for an individual patient {05})
Side/Adverse Effects
Note: Many symptoms typical of opioid withdrawal (listed below) occur during levomethadyl treatment. Early in treatment, while levomethadyl's active metabolites are forming and accumulating, such symptoms probably indicate withdrawal from illicit opioid analgesics. {01} {07} However, they may continue to occur many weeks after treatment has begun, especially on the days between doses. {01} Adjustment of levomethadyl dosage, {01} supplemental low doses of methadone, {01} {07} and/or a suppressant such as clonidine or guanabenz {07} may be needed.
In addition to the side/adverse effects listed below, the following have been reported in patients receiving levomethadyl (although a causal relationship has not been established): Amenorrhea; electrocardiographic irregularities, including prolongation of the QT interval and nonspecific ST-T wave changes; hepatitis; liver function test abnormalities; and pyuria.
The following side/adverse effects have been selected on the basis of their potential clinical significance (possible signs and symptoms in parentheses where appropriate)—not necessarily inclusive:
Those indicating need for medical attention
Incidence less frequent (1 to 3%) {23}
Edema (swelling of face, fingers, feet, and/or lower legs; weight gain)
mental depression
skin rash
Those indicating need for medical attention only if they continue or are bothersome
Incidence more frequent (3% or higher) {23}
Abdominal pain
general feeling of discomfort or illness
joint pain
sexual problems in males
trouble in sleeping
Incidence less frequent (1 to 3%) {23}
Back pain
blurred vision
CNS symptoms (anxiety; decreased sensitivity to stimulation; drowsiness; false sense of well-being; headache; unusual dreams)
decreased desire for sex
dry mouth
flu-like syndrome
hot flashes
nausea and vomiting
runny nose
Note: In some clinical trials, a significant number of patients experienced symptoms of stimulation, {15} {16} such as anxiety and nervousness, {15} on the day of administration. {15} {16} Some patients continued to experience these symptoms on the days between doses, {15} whereas others experienced symptoms such as lack of energy, dysphoria, and depression. {16}
Patients should be advised to report severe drowsiness or stimulation (e.g., feeling ``wired'') at the next visit to the clinic, because dosage adjustment may be needed. {23}
Incidence less than 1% {23}
Hypotension, postural (dizziness, lightheadedness, or feeling faint when rising from a lying or sitting position)
muscle pain
watery eyes
Those indicating possible withdrawal and/or the need for dosage adjustment or other treatment if they occur during therapy or after medication is discontinued
Body aches
fast heartbeat
increased sweating
loss of appetite
nausea or vomiting
nervousness, restlessness, or irritability
runny nose
shivering or trembling
stomach cramps
trouble in sleeping
unexplained fever
unusually large pupils of eyes
For specific information on the agents used in the management of levomethadyl overdose, see:
• Naloxone (Systemic) monograph; and/or
• Charcoal, Activated (Oral-Local) monograph.
For more information on the management of overdose, contact a Poison Control Center (see Poison Control Center Listing ).
Levomethadyl toxicity is more likely to develop when therapy is started in patients who have not developed tolerance to the effects of opioids. {01} In nontolerant patients, initial doses of 20 to 40 mg may cause somnolence, and larger initial doses may cause serious toxicity. Opioid-tolerant individuals may also experience symptoms, but at higher initial doses. {01}
Although overdose with levomethadyl alone has been reported rarely, as a result of too-frequent (daily) administration, most overdoses have involved ingestion of other opioids in addition to levomethadyl. {01} Deaths have occurred when patients continued to use illicit opioids after initiation of levomethadyl treatment. {07}
Clinical effects of overdose
The following effects have been selected on the basis of their potential clinical significance (possible signs and symptoms in parentheses where appropriate)—not necessarily inclusive:
Cold, clammy skin
low blood pressure
pinpoint pupils of eyes
respiratory depression (blue lips, fingernails, or skin; slow or troubled breathing)
severe dizziness, drowsiness, muscle weakness, nervousness, or restlessness
slow heartbeat
Note: In severe overdosage, extreme CNS and respiratory depression may result in apnea, shock, pulmonary edema, cardiac arrest, and death {01}.
Treatment of overdose
Primary importance should be given to maintaining adequate ventilation. Assessing the patient's respiratory status and, if necessary, administering oxygen or otherwise assisting respiration are essential. Provision of an artificial airway may be necessary. {01} {14}
To decrease absorption—Emptying the stomach by inducing emesis and/or administering activated charcoal {01}. The initial dose of charcoal should be followed by a cathartic, such as magnesium citrate, if the charcoal is not pre-mixed with sorbitol {17}. Gastric lavage may also be performed {14} {17}. During these procedures, care should be taken to protect the airway of any patient who is not fully alert {01}. However, treatment of respiratory depression or other life-threatening complications must take precedence {14}.
To enhance elimination—Forced diuresis, peritoneal dialysis, hemoperfusion, and hemodialysis are not likely to be effective for removal of levomethadyl because of its lipophilicity and large volume of distribution {01}.
Specific treatment—Administering naloxone, keeping in mind that rapid reversal of opioid effects may precipitate severe withdrawal symptoms, which may rarely lead to cardiac instability, in this patient population. Administration of several doses of naloxone, starting with considerably lower-than-usual quantities that may be increased gradually, if necessary, until the desired effect has been achieved is preferable to administration of large, single doses. Prolonged naloxone treatment, via repeated injections or continuous intravenous infusion, is likely to be necessary because of levomethadyl's long duration of action. Oral administration of the long-acting opioid antagonist naltrexone may precipitate prolonged withdrawal symptoms and is not recommended. {01} See the package insert or Naloxone (Systemic) for specific dosing guidelines for use of this product.
Respiration, oxygenation, patient alertness, and vital signs should be monitored {01}. Because of levomethadyl's long duration of action, prolonged observation will be needed. {01}.
A screen for other medications, especially other drugs of abuse, should be performed {01} and additional treatment instituted as required.
Supportive care—
Supportive measures include establishing intravenous lines, hydration, and administering vasopressors if necessary. {14}
Patient Consultation
As an aid to patient consultation, refer to Advice for the Patient, Levomethadyl (Systemic).
In providing consultation, consider emphasizing the following selected information (» = major clinical significance):
Before using this medication
» Conditions affecting use, especially:
Sensitivity to levomethadyl
Pregnancy—Not starting levomethadyl during pregnancy; methadone is preferred medication for treating pregnant opioid addicts
Use in children—Use in patients up to 18 years of age not permitted by U.S. Federal regulations
Other medications, especially alcohol or other CNS depressants, hepatic enzyme inducers or inhibitors, other opioid analgesics, and opioid antagonists
Other medical problems, especially cardiac arrhythmia, diarrhea caused by antibiotics or by poisoning, asthma or other respiratory problems, and severe inflammatory bowel disease
Proper use of this medication
» Medication usually taken at clinic 3 times per week; at home doses permitted if patient is deemed responsible
» Proper dosing
Precautions while using this medication
» Importance of compliance with other measures necessary for rehabilitation, e.g., counseling, attending support group meetings, making lifestyle changes
» Avoiding use of alcoholic beverages and illicit opioids or other CNS depressants during therapy, even if experiencing withdrawal symptoms and cravings, because of the risk of potentially fatal additive toxicity or overdose
» Caution if severe drowsiness occurs, especially when treatment initiated or dosage adjusted
» Getting up slowly from a lying or sitting position; lying down for a while may relieve symptoms associated with postural hypotension, such as dizziness, light-headedness, or feeling faint
» Need to inform physicians and dentists of levomethadyl use, particularly if any kind of surgery (including dental surgery) or emergency treatment is required
Possible need for regimen to prevent severe constipation
Possible dryness of mouth; using sugarless gum or candy, ice, or saliva substitute for relief; checking with dentist if dry mouth continues for more than 2 weeks
» Female patients only: Not becoming pregnant during treatment; discussing planned pregnancy with counselor ahead of time; informing counselor if pregnancy suspected
» If transferring to methadone: Not taking first dose of methadone for at least 48 hours after last dose of levomethadyl
» Suspected overdose: Getting emergency help at once; need to inform emergency practitioners that the patient is physically dependent on a long-acting opioid, naloxone is likely to precipitate withdrawal, and prolonged observation and monitoring are needed
Side/adverse effects
Getting emergency help immediately if respiratory depression or other symptoms of overdose occur
Signs and symptoms of other potential side effects, especially edema, mental depression, and skin rash
Informing counselor at clinic if severe drowsiness, severe stimulation, or withdrawal symptoms occurred after previous dose
General Dosing Information
In the U.S., levomethadyl is available only through treatment programs that have been approved by the Food and Drug Administration, Drug Enforcement Agency, and designated state authorities {01} {05}.
Levomethadyl is given only by the oral route. The commercially available oral solution must be diluted before being administered to the patient. Treatment centers that dispense both levomethadyl and methadone (which must also be dispensed as a dilute liquid) should use liquids of different colors for preparing each medication, so that they can be distinguished from each other readily. {01} {05}
Levomethadyl is to be ingested by the patient at the treatment center. If it is determined that the patient is responsible in handling opioid drugs then levomethadyl take-home doses are permitted.{24}{01}{05}.
Levomethadyl treatment should be initiated using a dose that suppresses withdrawal symptoms and decreases craving for illicit opioids without inducing excessive opioid effects {01}. Interpatient variability in levomethadyl kinetics and each patient's level of tolerance to opioids must be taken into account when selecting initial dosage {01}. However, because of levomethadyl's slow onset of action and the risk of toxicity if dosage is increased too rapidly, elimination of withdrawal symptoms and craving may not be possible during the first 1 or 2 weeks of therapy {01}. Patients may need extra counseling and support {01} and/or administration of a withdrawal suppressant, preferably a non-opiod such as clonidine or guanabenz, {07} during this time. Alternatively, treatment may be initiated with methadone (especially if the patient's degree of tolerance to opioids is not known), since effective dosage can be achieved more rapidly, and the patient transferred to levomethadyl after a few weeks {01}. The changeover from methadone to levomethadyl may be accomplished in a single dose {01}.
Levomethadyl is usually administered 3 times a week (on Monday, Wednesday, and Friday or on Tuesday, Thursday, and Saturday), {01} but some patients experience withdrawal symptoms during the 72-hour Friday-to-Monday or Saturday-to-Tuesday interval {01} {07}. Administration of a higher dose on Friday or Saturday prevents or minimizes this problem in most patients {01} {07}. However, in a clinical trial patients receiving such a regimen reported feeling overmedicated on the day that the higher dose was given and undermedicated after the next (lower) dose {18}. For some patients, use of a withdrawal suppressant such as clonidine or guanabenz {07}; provision of a low take-home dose of methadone (if the patient meets the criteria specified in U.S. Federal regulations for take-home methadone) {01} {07}; arranging the patient's schedule so that the 72-hour interval occurs during the week, so that a small dose of methadone can be administered to the patient at the clinic if necessary {01}; or administration of levomethadyl on an every-other-day basis {01} may be necessary. Levomethadyl should not be administered daily because rapid accumulation of the medication and its active metabolites may lead to an overdose {01}.
Patients receiving levomethadyl may be transferred directly to methadone {01} {19}, although some patients may experience mild withdrawal symptoms during the first 1 or 2 weeks {19}. The initial dose of methadone, which should be taken at least 48 hours after the last dose of levomethadyl, should be 80% of the patient's lower levomethadyl dose. For example, a patient receiving three-times-a week treatment with 80, 80, and 100 mg of levomethadyl would be given 64 mg of methadone per day, initially. The daily dose of methadone may be increased or decreased by 5 or 10 mg if symptoms of withdrawal or opioid excess occur. {01} This regimen may also be used, provided that the regulations and requirements for take-home methadone are met, when a levomethadyl-treated patient who is unable to attend the clinic regularly for a period of time (for example, because of illness or travel) requires a temporary transfer to take-home methadone. {01} {05} The risk of the methadone's being diverted to illicit use must be considered. The number of take-home methadone doses should be 2 fewer than the number of days of expected absence, but must not exceed the maximum number of take-home doses specified in U.S. Federal regulations. When the patient returns to the clinic levomethadyl may be resumed, following the same dosage regimen as before the temporary change in treatment. However, if the last methadone dose was taken more than 48 hours previously, levomethadyl should be reintroduced at a dose based on clinical and/or toxicological evaluation of the patient. {01}
Discontinuation of levomethadyl maintenance therapy may be considered after the patient has achieved behavioral objectives outlined in the patient's comprehensive treatment plan, i.e., stopped using illicit drugs, reached social and occupational goals, and changed his or her lifestyle to decrease the risk of relapse. Treatment should not be stopped prematurely, and appropriate nonpharmacological support should be provided to reduce further the risk of relapse. Stable long-term treatment is preferable to cycles of discontinuation of therapy followed by recidivism. {01} Treatment has been successfully discontinued by abrupt withdrawal or by reducing dosage gradually (by 5 to 10% per week). {01} One study comparing both methods of detoxification found that withdrawal symptoms were not more severe, and a significantly higher number of patients were successfully withdrawn from maintenance treatment without returning to illicit opioid use, when levomethadyl was stopped abruptly. {20}
Safety considerations for handling this medication
Because of the risk of diversion of this potent opioid, security measures stipulated in the U.S. Federal Code of Regulations should be taken to safeguard supplies of the medication {01} {03}.
There are no known hazards associated with dermal or aerosol exposure to levomethadyl. However, if the medication is spilled onto an individual, contaminated clothing should be removed and the exposed skin rinsed with cool water {01}.
Oral Dosage Forms
Usual adult dose
Opioid (narcotic) abuse therapy adjunct
Patients not receiving prior methadone maintenance treatment—Oral, 20 to 40 mg for the first dose. Subsequent doses, given at forty-eight- or seventy-two-hour intervals, may be increased by 5 to 10 mg until the desired effects (absence of withdrawal symptoms and decreased craving for illicit opioids) have been achieved or decreased by the same amount if undue sedation or other symptoms of opioid excess occur. {01}
Patients transferred from methadone maintenance treatment—Oral, a quantity of levomethadyl equivalent to 1.2 to 1.3 times the patient's daily methadone dose, up to a maximum of 120 mg, for the first dose. Subsequent doses, administered at forty-eight- or seventy-two-hour intervals, should be adjusted according to the response of the individual patient, using caution not to increase the dose too rapidly because of the risk of toxicity. Dosage is generally increased by 5 to 10 mg every second or third dose. {01}
Dosage must be individualized according to the patient's tolerance and response. Most patients can be stabilized on 60 to 80 mg, administered three times a week at forty-eight- or seventy-two-hour intervals. However, maintenance doses as low as 10 mg and as high as 140 mg, administered three times a week, have been used in clinical trials. If necessary to prevent withdrawal over a seventy-two-hour interdose interval, the dose prior to this interval may be increased, in 6- to 10-mg increments, to up to forty percent higher than the doses given prior to a forty-eight-hour interval. At least two weeks are required to achieve a new clinical plateau after each adjustment of levomethadyl dosage.{01}
Following an unplanned lapse of one dose:
—If the patient comes to the clinic to be dosed on the day following a missed scheduled dose (misses Monday, arrives Tuesday) the regular Monday dose should be administered on Tuesday, with the scheduled Wednesday dose administered on Thursday and the Friday dose given on Saturday. The patient's regular schedule may be resumed the following Monday (missed Wednesday, receives the regular dose on Thursday and Saturday, and returns to the regular Monday/Wednesday/Friday dosing schedule the next week).{24}
—If a patient misses one dose and comes to the clinic on the day of the next scheduled dose (misses Monday, arrives Wednesday), the usual dose will be well tolerated in most instances, although a reduced dose may be appropriate in selected cases.{24}Following an unplanned lapse of more than one dose:
—Patients should be reintroduced at an initial dose of 1/2 or 3/4 their previous levomethadyl dose, followed by increases of 5 to 10 mg every dosing day (48 or 72 hour intervals) until their previous maintained dose is achieved. Patients who have been off of treatment for more than one week should be reinducted.{24}
Note: U.S. Federal regulations require that single doses of 140 mg or more be justified in the patient's record {05}.
Usual adult prescribing limits
Initial induction dose—40 mg (if the patient's level of opioid tolerance is unknown) or 120 mg (if the patient's level of tolerance, based on methadone dosage requirements, is known). {01}
Maintenance—Dosage should not exceed 140 mg three times a week or every other day, or two 130-mg doses and one 180-mg dose per week. {01}
Usual pediatric dose
U.S. Federal regulations prohibit use of levomethadyl in patients younger than 18 years of age {01} {05}.
Usual geriatric dose
See Usual adult dose.
Strength(s) usually available
10 mg per mL (Rx) [Orlaam{01} (methylparaben 1.8 mg ) (and propylparaben 0.2 mg per mL)]
Not commercially available.
Packaging and storage:
Store between 15 and 30 °C (59 and 86 °F), protected from freezing, unless otherwise specified by manufacturer.
Preparation of dosage form:
U.S. Federal regulations stipulate that the oral solution must be diluted before being administered to the patient. The liquid used for dilution should be colored differently than a liquid used to prepare methadone solutions in the same clinic {01} {09}.
Developed: 08/11/1995
Revised: 08/05/2001
- Orlaam package insert (Bio-Development—US), Rec. 9/93.Undated
- Fleeger C, editor. USP dictionary of USAN and international drug names. 1995. Rockville, MD: The United States Pharmacopeial Convention, Inc., 1994: 382.
- Human drugs: Drugs for narcotic addiction treatment—Levo-alpha-acetyl-methadol, 38704. Department of Health and Human Services, Food and Drug Administration. Fed Regist 58 (137) 1993 Tuesday, July 20.
- Schedules of controlled substances: Levo-alphacetylmethadol, 43795. Department of Justice, Drug Enforcement Administration. Fed Regist 58 (158) 1993 Wednesday, August 18.
- 291.505. Conditions for the use of narcotic drugs; appropriate methods of professional practice for medical treatment of the narcotic addiction of various classes of narcotic addicts under section 4 of the Comprehensive Drug Abuse Prevention and Control Act of 1970. Code of Federal Regulations. 21: Food and Drugs. Washington, Office of the Federal Register, National Archives and Records Service, General Services Administration; for sale by the Supt of Docs, U.S. Govt Print Off. 1994; 124-45.
- Drugs Directorate Guidelines. The use of opioids in the management of opioid dependence. Ottawa, Ont: Health Protection Branch, Health and Welfare Canada, 1992 August.
- Tennant FS, Rawson RA, Pumphrey E, et al. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM). J Subst Abuse Treat 1986; 3: 195-202.
- Brusick D, Matheson D, Jagannath D, et al. Genetic screening of compounds used in drug abuse treatment. III. LAAM. Drug Chem Toxicol 1981; 4: 19-35.
- Toro-Goyco E, Martin BR, Harris LS. Binding of l-alpha-acetylmethadol and its metabolites to blood constituents. Biochem Pharmacol 1980; 29: 1897-902.
- Henderson GL, Wilson BK, Lau DHM. Plasma l-alpha-acetylmethadol (LAAM) after acute and chronic administration. Clin Pharmacol Ther 1977; 21: 16-25.
- Finkle BS, Jennison RA, Chinn DM, et al. Plasma and urine disposition of l-alpha-acetylmethadol and its principal metabolites in man. J Anal Toxicol 1982; 6: 100-5.
- Kaiko RF, Inturrisi CE. Disposition of acetylmethadol in relation to pharmacologic action. Clin Pharmacol Ther 1975; 18: 96-103.
- Lichtblau L, Sparber SB. Outcome of pregnancy in rats chronically exposed to l-alpha-acetylmethadol (LAAM). J Pharmacol Exp Ther 1981; 218: 303-8.
- Opioid (Narcotic) Analgesics (Systemic) monograph draft for USP DI 1986.
- Zangwell BC, McGahan P, Dorozynsky L, et al. How effective is LAAM treatment? Clinical comparison with methadone. NIDA Res Monogr 1986; 67: 249-55.
- Marcovici M, O"Brien CP, McLellan AT, et al. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction. Am J Psychiatry 1981; 138: 234-6.
- Clinical Toxicology/Substance Abuse panel meeting 4/19/94.
- Hough G, Washton AM, Resnick RB. Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy. NIDA Res Monogr 1983; 43: 302-9.
- Ling W, Blakis M, Holmes ED, et al. Restabilization with methadone after methadyl acetate maintenance. Arch Gen Psychiatry 1980; 37: 194-6.
- Judson BA, Goldstein A, Inturrisi CE. Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of graduated and abrupt detoxification. Arch Gen Psychiatry 1983; 40: 834-40.
- ReVia (naltrexone) package insert (DuPont Pharma—US), Rev 1/95, Rec 2/95.
- Panel comments, monograph draft 5/95.
- Orlaam package insert (Roxane—US), Rec. 7/95.Undated
- Product Information: Orlaam®, levomethadyl. Roxane Laboratories, Columbus, Ohio. (PI revised 5/2001) PI reviewed 7/2001
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.


text:
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Looking at education as if looking through a microscope. Identifying issues and problems and different ways to solve them.
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.


text:
Leecat is correct - I tried that with a view to saving battery consumption and got the red LED the following morning which worried me a bit. When I equalised the pressure and evacuated the housing again, all was well. Didn't understand why but Leecat's explanation has removed a minor niggle at the back of my mind.
I confirm Okuma's experience of this unit - just dived two weeks in Scotland using the Leal Sentinel on an Aquatica housing and it worked flawlessly.


text: Howdy, Had issues a couple of days ago with Litespeed I ended up getting a new license as it was about to be renewed anyway... problem fixed. Now all of a sudden I'm getting "403 Forbidden - Access to this resource on the server is denied!" I think CSF is blocking Litespeed. How would I go about adding Litespeed to CSF's whitelist? Or is it more likely the user that Litespeed is using is being blocked? Cheers


text:
|Send News. Want a reply? Read this. More in the FAQ. News Forum - All Forums - Mobile - PDA - RSS Headlines Twitter
ArenaNet Blog now offers a new look at Guild Wars 2 called "The Evolution of Narrative in Personal Story" written by Leif Chappelle, one of the developers of the upcoming MMORPG sequel. Leif recaps the concept of personal stories, and details the process the team uses to create them. Thanks Cutter.
Copyright © 1996-2018 Stephen Heaslip. All rights reserved.
All trademarks are properties of their respective owners.
Privacy Policy.
News CGI copyright © 1999-2018 James "furn" Furness &
Blue's News.
All rights reserved.
Chatbear v1.4.0/blue++: Page generated 24 May 2018, 21:31.
Chatbear Announcements.


text:
I feel like there is a big difference between telling a kid that he has a spot, and then greyshirting him and greyshirting him upfront. I do agree that this is something that I would not like to see become commonplace, but if Jeremy is that excited to be a Wolverine and happy to take the spot then I'm all for it.
TomVH: Kentucky Safety Jeremy Clark Offered a Greyshirt
A name that has been popping up a lot since Michigan's camp is Kentucky safety Jeremy Clark. The 6-foot-4, 205-pound defensive back went up to Michigan to show the coaches what he has to offer. He now finds himself in a unique scenario, and I caught up with his coach today to talk about where Jeremy is at.
"He was offered a greyshirt today by the coaches, which could eventually lead to being a part of this class if the other safety they're in on doesn't commit," his coach said. The other safety he's talking about is likely Ohio defensive back Jarrod Wilson, who could be deciding as early as tomorrow.
To those that aren't familiar, a greyshirt would mean Jeremy would commit to Michigan and pay his way through school, likely only for a semester. Once the semester is up he would then be able to earn a scholarship, the greyshirt preserves his eligibility while not counting towards the 2012 class numbers.
"He's going to talk to his dad tonight and make a decision soon. He really fell in love with Michigan and the coaches," said his coach. "He said the facilities, the tradition, and the coaches just made him feel at home. He said it just felt right." Deciding to take the greyshirt from Michigan would show just how interested he is since he would be passing up full rides from North Carolina State, Akron, Ball State, CMU, Illinois, Ohio, and Toledo.
"Jeremy is a great kid, kind of quiet, but very hard worker. As far as on the field, he's a head hunter. I coached a kid that went to Notre Dame as a safety, and I think Jeremy has potential to be better," said his coach. Jeremy is a big defensive back at 6-foot-4, but his coach reports he ran a 4.4 forty time at both Kentucky and Cincinnati's camp. "He'll come down hill and play hard nosed football, too. He's got size and speed, and he just grew three to four inches in the last year. He went from being undiscovered to blowing up."
Clark's coach isn't sure when he'll decided but is supposed to speak with his father tonight to go over what exactly a greyshirt is. "I told Jeremy what [a greyshirt] is, so I'll tell his dad tonight," he said. "I don't know when he'll decide but I know he was as excited as I've ever seen him that Michigan still wanted him." It sounds like Clark could make his decision soon. The Michigan coaches explained to him that he can take the greyshirt and if Jarrod Wilson were to commit elsewhere then Clark would take that spot for the 2012 class.
I noted in a previous thread that Sam Webb (on Wednesday's recruiting roundup; podcasts here) was raving about Clark's performance at Michigan's camp on Tuesday.
Here is Clark's highlight video:
Reminds me a little of a Standifer version of a safety
For those not blown away by his film (you can include me in that category) the rumor is that he really tore up Michigan's camp, big time. So this is another 'trust-the-coaches' call. Which I do, since they've given me no reason not to
I trust the coaches to, but that reasoning is kind of silly. They also haven't given you a reason to trust their judgement, as they haven't coached a game before.
That being said, I do trust them. And I would love a 6'4 safety..
Maybe not as coaches, but as recruiters and talent identifiers? They were on Standifer before the other powerhouses. They were on Odenigbo before the other powerhouses. They were in on Aziz Shittu before the powerhouses. I think they've given plenty of reason to trust their ability to identify talent.
no offense but that still doesn't show us anything. You still can't say they are great at identifying talent when those players haven't even stepped on the field yet. How do we know any of these guys will pan out ( not that I think they won't)?
In all seriousness, I am excited about how things have gone since Hoke got here, but all this "trust the coaches" stuff is insane. They haven't coached one game and have yet to have one single recruit step on the field to prove they knew what they were doing when they offered. Let's just let these guys prove themselves before we annoint them the saviors of our beloved wolverines.
To be clear, I am excited but trying to maintain some objectivity.
Fair enough. That said, it's ALL WE HAVE to go on, so it's what we use, mmmmkay?
DGDestroys has it right. I love what I'm seeing so far and trust their judgements 100%.
Edit: The coaches are being up front and transparent about the conditional "offer". The kid can decide if it fits for him or not.
I felt sordid and unusal when I saw the term "Greyshirt" but I don't know that I have a problem with this. It's all up front and above board. We're not going to violate scholarship numbers, no one is being lied to, no one is being cut on account of this. The fact that all of this is being done in the light of day is a fairly clear sign this is being done correctly. Basicall he'd be agreeing to be a walk-on for a semester. There's nothing inherently illegal about that.
I only have a problem with it if the kid arrives on campus and then finds out he's getting a greyshirt, a la the SEC schools, but if the Michigan coaches they have told Clark up front, it's fine. It's the player's choice to take it or not.
The threshold for judging this is honesty. If the coaches are honest about it and everyone is on board, it's just another technique to get a kid on the team who wants to be on the team.
I also like kids like Jeremy Clark, who are growing late and often have upside that is just now becoming visible. I hope it works out for him. He's a big safety, that's for sure.
A greyshirt at UofM seems a bit different compared to other schools. They let the kid know right from the start, just like a walk on.
Don't forget that Morales was a greyshirt at Michigan also. So this is nothing new there.
Kudos to the staff for being honest with the kid. It is nice to know where you stand even if you are option #2.
With Wilson's decision imminent, I don't see Clark being in a hurry to pull the trigger before Wilson unless he really, really wants to be at Michigan -- which sounds like it may be the case, but he hasn't spoken to his parents yet and they hold the checkbook.
It sounds like Jeremy changed a lot, from a physical point of view, recently. As a result, based on all of his old measurables, film, etc., people at the bigger programs didn't see him as a major conference player.
However, in light of the fact that he is showing up at UM camp with a whole new body, showing what he can do and turning heads, Michigan is reevaluating him.
It could be a great fit for all, in that Jeremy could get into a top flight football program, as opposed to the mid-levels that have offered him up to this point, and Michigan (by use of a one semester greyshirt) can get a player that we can use, who we probably do not have an immediate scholarship for.
He only has to pay for one semester (if Tom is correct), and we get a nice, up and comer kind of player. Given that his coach and his dad are in on the process, I would expect that he will be well counseled and make an informed decision.
Depending on how Jeremy feels about his other options, this might work out well to everyone's benefit. He sure has those measurables now from the sound of it . . .
TomVH says:
"To those that aren't familiar, a greyshirt would mean Jeremy would commit to Michigan and pay his way through school, likely only for a semester. Once the semester is up he would then BE ABLE TO EARN a scholarship . . . "
Being able to earn a scholarship is a far cry from a GUARANTEED full scholarship after a semester.
Does he get a scholarship if gets hurt? What if he's just not as good as the coaches had hoped? What if he is as good as the coaches had hoped, but they find better in the 2013 class?
That's exactly what I'm wondering. Is there any guarantee of a scholarship down the road?
Even for players on full scholarship its a year-to-year commitment, so there is never a guarantee beyond what you have now.
I too feel uneasy about this, but have faith in our coaching staff to handle this with integrity. As long as its within the rules, and the family has full disclosure of what they are getting themselves into, I have no problem with it.
TVH was not as precise in his words as you would have guessed. If he accepts the offer, he'll get a scholarship from next year's class (or in reality from a nonreturner after that).
There is aboslutely zero problem with offering a greyshirt here. There's no moral implications or anything dirty. Legitimate greyshirts exist. The problem is when a kid THINKS they're getting a full scholarship, enrolls, gets to campus, and then is informed, "Oh yeah, you're paying for everything."
I love that they're doing it this way, and maybe we can end up with both Clark and Wison in this class.
Yes, this is true. Unlike Les MIles, who offered a scholie, and the kid shows up to pay for his first semester, and then gets a scholie if he looks good in practice.
to tell me how to feel about this.
But congratulations to this kid, the coaches do want him. I heard Sam talking about this kid, and apparently he tore it up at camp
It's crazy how these southern kids came in and dominated the UM camp. According to Sam Webb, Jeremy Clark was someone who really stood out from the pack. Also it sounds like the top 2013 athlete was Shaquille Wiggins, from Georgia. That sort of worries me.
If we are at the 85 limit how are they going to give him a scholarship in January?
Its unlikely it would be guaranteed to last only a semester. It would just mean he is the first guy on scholarship when one freed up. Its more a of a guarantee that he would be on scholarship at the end of his freshman year.
just take one less scholarship player in the '13 class.
It would be January of 2013, and he would basically take somebody's spot from that incoming class, as opposed to this one.
Or a potential 5th yr. player is not offered continuation of his scholie.
Same deal with early-enrolees. In scholarship terms an EE and a greyshirt are the same because the scholly starts in January.
For some reason, I guess EE's / greyshirts dont affect the 85 limit. Don't you only have to be under 85 by a certain date, by which departing seniors are off scholarhsip?
Scholarships are counted on a calendar-year basis, so the seniors who exhaust their eligibility with the 2011 football season will no longer count toward the 85-scholarship limit on January 1, 2012. From oversigning.com:
5. Gray shirt - the NCAA rules state that college football players have 5 calendar years to complete 4 seasons of play. When a recruit enters the program they can defer scholarship benefits until the following calendar year. This restricts them from certain team activities, but in terms of the scholarship numbers they don't count until the following year. Often times, coaches will ask borderline guys to take a gray shirt (if they can afford it) to free up a scholarship. This usually applies to players who would be considered tweeners between being a walk-on player or a scholarship player.
Does he still sign a LOI?
I don't understand the big deal? When a kid is offered a scholarship and gets redshirted, he gets 5 years of free school. It works both way people.
This is confusing my little pea brain. What if a player leaves the team next summer. Would he be able to take that scholarship immediately, and never have to pay any tuition?
That is exactly what it means.
Yes...take it from random internet guy...or talk to Mr. Google... ;-)
basically a 'preferred walk on' status? I don't know much about this because, as far as I can remember, we have never done it. I could be wrong.
IIRC Slocum and before that one of the Sarantos brothers. We didn't use to get this much info, so it probably happened more than that It's different from being a preferred walk-on because he is guaranteed a scholarship in 2013.
I don't have a problem with it. It doesn't matter at all how I feel about it, but I just thought I'd put it out there. I'm actually very glad because this proves the coaches are being straightforward and honest with the recruits. Tell it like it is.
If he wants to come, then he's proving how much he wants to be a Wolverine, and I love that. Congrats to Jeremy, and good luck!
... how about offering him a Blueshirt? It's similar to a Greyshirt but the kid gets a scholarship from day 1. The trick is he cannot sign a LOI, but must instead trust the integrity of the coach to honor the deal when he shows up on campus.
If that height and 40 time are correct, I wonder if the kid might get a look at wide receiver. You don't see many 6'4" receivers who run a 4.4.
Does this mean things aren't looking good with Wilson?
No, that's not what it means.
If Wilson commits, Clark would have to wait until 2013 to get a scholarship. That's what "greyshirt" means.
If Wilson goes elsewhere, Clark will get an offer for a full ride.
Well, I meant to ask are we (kinda) offering another safety because we aren't looking good with Wilson? Or is he getting a greyshirt offer because we are confident with Wilson? Or am I just reading into this too much because I am incredably bored with too much time on my hands?
My read is this is a positive about Wilson. Clark isn't exactly going to commit elsewhere before Wilson announces so the staff could just hold off entirely until then. And if Wilson was going elsewhere, then why offer the greyshirt? They would just offer Clark a regular scholarship. This suggests they want Clark but don't have room for him in 2012 because of Wilson.
On September 23rd when they visit Owensboro and play at Rash Stadium.
I hope Wilson decides sooner rather than later wether it's here or elsewhere. Just so he can decide whether or not he wants to accept a greyshirt status. Also, I hope his parents can afford it. I think somebody had a thread about the cost of tuition. I might be wrong, but I think it was around $37K for out of staters.
His family would only be footing a semester's worth of out-of-state tuition, since he'd be on scholarship starting in Jan 2012. It's still a lot, but if you consider that money over 4-5 years of school, it's not so bad.
Plus, for the same reason I respect walk-ons who turn down lesser schools, if this kid chooses to grey shirt at UM, I will respect him all the more. I love to see kids who are dead set on being a Wolverine. Those type of players almost always help with team unity and effort.
If this article is accurate, it wouldn't be surprising to see him get some better offers and/or ratinds after his senior year.
Am I the only one who sees "6'4'' and 4.4 40-time" in the same sentence and wonders why there isn't a WR next to this kid's name?
They are at the end of your wrists.
Bad-ass Karate Kid-style wristbands? That doesn't seem like something that would preclude a kid from being a wideout...
Yes, I understand we are being "upfront" about the situation. Yes, I understand that it is "just like a preferred walk-on status."
Q: Why aren't we calling it a preferred walk-on position, then? It's no different, right? Why sell it as a different thing, then? It seems to imply a guarantee that doesn't exist.
I don't like this one bit.